Rankings
▼
Calendar
EVAX FY 2025 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena
EVAX
Evaxion Biotech A/S
$20M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
+125.8% YoY
Gross Profit
$0
0.0% margin
Operating Income
-$9M
-122.7% margin
Net Income
-$8M
-102.4% margin
EPS (Diluted)
$-1.21
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$28M
Total Liabilities
$11M
Stockholders' Equity
$17M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$3M
+125.8%
Gross Profit
$0
$3M
-100.0%
Operating Income
-$9M
-$15M
+37.1%
Net Income
-$8M
-$11M
+26.8%
← Q4 2024
All Quarters
Q1 2025 →